Synergistic antitumor efficacy of sequentially combined paclitaxel with sorafenib in vitro and in vivo NSCLC models harboring KRAS or BRAF mutations
Zhang, Xiang-Hua, Shin, Jung-Young, Kim, Jeong-Oh, Oh, Ji-Eun, Yoon, Seong-Ae, Jung, Chan-Kwon, Kang, Jin-Hyoung
Published in Cancer letters (28.09.2012)
Published in Cancer letters (28.09.2012)
Get full text
Journal Article
Proposal of pharmacogenetics-based warfarin dosing algorithm in Korean patients
Choi, Jung Ran, Kim, Jeong-Oh, Kang, Dae Ryong, Yoon, Seong-Ae, Shin, Jung-Young, Zhang, XiangHua, Roh, Mee Ork, Hong, Hyung Joo, Wang, Young-Pil, Jo, Keon-Hyon, Lee, Kwang-Soo, Yun, Ho-Jung, Oh, Yong-Seog, Yoo, Ki-Dong, Jeon, Hee-Gyeong, Lee, Yoon Sook, Kang, Tae Sun, Park, Hyun-Joo, Chung, Myeon Woo, Kang, Jin-Hyoung
Published in Journal of human genetics (01.04.2011)
Published in Journal of human genetics (01.04.2011)
Get full text
Journal Article
Purification and Characterization of Branching Specificity of a Novel Extracellular Amylolytic Enzyme from Marine Hyperthermophilic Rhodothermus marinus
YOON, Seong-Ae, RYU, Soo-In, LEE, Soo-Bok, MOON, Tae-Wha
Published in Journal of microbiology and biotechnology (01.03.2008)
Get full text
Published in Journal of microbiology and biotechnology (01.03.2008)
Journal Article
Purification and Characterization of Branching Specificity of a Novel Extracellular Amylolytic Enzyme from Marine Hyperthermophilic Rhodothermus marinus
Yoon, Seong-Ae, Ryu, Soo-In, Lee, Soo-Bok, Moon, Tae-Wha
Published in Journal of microbiology and biotechnology (30.03.2008)
Get full text
Published in Journal of microbiology and biotechnology (30.03.2008)
Journal Article
NOVEL COMPOUNDS FOR SELECTIVE HISTONE DEACETYLASE INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THEREOF
KO, EUN HEE, LIM, HYO JIN, LEE, CHANG SIK, KIM, DO HOON, KIM, SO YOUNG, CHOI, HO JIN, YANG, HYUN MO, HA, NI NA, YOON, SEONG AE, BAE, DAE KWON
Year of Publication 06.11.2014
Get full text
Year of Publication 06.11.2014
Patent
Abstract 1582: Rho GDP dissociation inhibitor 2 (RhoGDI2) plays a functionally important role on EGFR signaling pathway in adenocarcinoma cells of lung cancer
Shin, Jung-Young, Zhang, Xiang-Hua, Yoon, Seong-Ae, Chae, Hiun Suk, Kang, Jin-Hyoung
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Get full text
Journal Article
Abstract A81: Synergistic antitumor efficacy of the multikinase inhibitor, sorafenib and paclitaxel combination in NSCLC tumor model
Jeon, Eun Kyoung, Zhang, Xiang-Hua, Shin, Jung-Young, Yoon, Seong-Ae, Kang, Jin-Hyoung
Published in Molecular cancer therapeutics (10.12.2009)
Published in Molecular cancer therapeutics (10.12.2009)
Get full text
Journal Article
Abstract 3618: Synergistic anti-tumor efficacy of a multi kinase inhibitor, Sorafenib combined with Paclitaxel in vitro and in vivo lung cancer models
Zhang, Xiang-Hua, Shin, Jung-Young, Yoon, Seong-Ae, Chang, Myung-Hee, Hong, Sook-Hee, Kang, Jin-Hyoung
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Get full text
Journal Article